glp 1 agonists vs sglt2 inhibitors GLP-1 Receptor Agonist Therapy With and Without in Patients With Type 2 Diabetes Frontiers | Effects of SGLT2

Mast cell stabilizer (MCAS Connection): GLP-1 receptors are also found on mast cells, and recent studies have shown that GLP-1 RA drugs prevent overactive mast cell degranulation

Evidence-based GLP-1 care Custom-formulated compounded medications using ingredients commonly prescribed in medical practice

Use of any of these antihyperglycemic medications is not without risk, however, and the choice to use any of these agents in a patient should consider both potential risks and benefits of therapy

*Correspondence: Daiji Kawanami, [email protected] This article was submitted to Renal Pharmacology, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

doi: 10.1007/s00125-019-4839-8

To counter such impacts, some companies are exploring ways that GLP-1RA drugs could complement their existing solutions